Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Ribo Biology-B (06938.HK) repurchased 38,200 shares on October 23 for HK$1.821 million.
23/10/2026
Zhitong Finance APP News, Ribo Bio-B (06938.HK) announced that on October 23, 2026, it spent HK$1.821 million to repurchase 38,200 shares.
Latest
2 m ago
Meet Xiaomian (02408.HK) repurchased 107,000 shares on October 23 for approximately HK$405,400.
2 m ago
China National Building Material (03323.HK) reported a net loss attributable to shareholders of RMB 728 million for the first three quarters.
3 m ago
Keanda (002972.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 49.4579 million yuan, a year-on-year decrease of 17.63%.
4 m ago
Surgical-B (02675.HK) repurchased 56,400 shares on October 23 at a cost of approximately HK$1.7828 million.
5 m ago
Oracle: Will invest $1 billion in partner ecosystem over 4 years.
See all latest